Global Extracorporeal Membrane Oxygenation Device Market Size By Type (Veno Artrial (VA), Veno Venous (VV)), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Extracorporeal Membrane Oxygenation (ECMO) Device Market was valued at USD 610 million in 2023 and is projected to surpass USD 1.12 billion by 2031, expanding at a CAGR of 7.9% during the forecast period (2023–2031). ECMO devices, critical in managing cardiac and respiratory failure, have gained prominence due to rising incidences of cardiopulmonary diseases, growing prevalence of respiratory disorders like ARDS and COPD, and their essential role in advanced life support, especially during pandemics and post-operative care.

Drivers:

Rising Prevalence of Cardiopulmonary Disorders:

An increasing global burden of cardiac and respiratory diseases is significantly boosting the demand for ECMO devices in intensive care units and emergency departments.

Advancements in ECMO Technology:

Ongoing innovations such as portable ECMO systems, hybrid devices, and integration with real-time monitoring are enhancing clinical outcomes and expanding usage.

Increased Use in Pediatric and Neonatal Care:

ECMO is widely used in neonatal intensive care units (NICUs) for respiratory support, creating steady demand, particularly in developed countries with advanced healthcare infrastructure.

Restraints:

High Cost and Maintenance Requirements:

ECMO systems require substantial initial investment, trained personnel, and continuous maintenance, limiting their adoption in cost-sensitive or under-resourced healthcare settings.

Risk of Complications and Skilled Operation Requirement:

Complications such as bleeding, thrombosis, and infections, coupled with the necessity of specialized clinical teams, can hinder widespread implementation.

Opportunities:

Emerging Market Penetration:

Growing healthcare infrastructure in countries across Asia-Pacific, Latin America, and the Middle East presents an untapped opportunity for ECMO device manufacturers.

Integration with AI for Monitoring and Prognostics:

The adoption of AI-based decision support systems in critical care is expected to revolutionize ECMO management by enhancing precision and reducing complications.

Market by System Type Insights:

Based on system type, the veno-arterial (VA) ECMO segment led the market in 2023, driven by its usage in severe cardiac failure cases and cardiogenic shock. VA ECMO provides both cardiac and respiratory support, making it a preferred choice in critical care scenarios. However, the veno-venous (VV) ECMO segment is anticipated to grow at a higher CAGR during the forecast period due to its rising application in respiratory support and COVID-19-related ARDS treatment cases.

Market by End-use Insights:

The hospital segment dominated the ECMO device market in 2023, accounting for over 60% of the total share. Hospitals are primary end-users due to availability of critical care infrastructure, ECMO-trained staff, and emergency departments. Meanwhile, specialty clinics and ambulatory surgical centers are gradually adopting ECMO support systems, particularly in developed regions, as part of post-operative care enhancements.

Market by Regional Insights:

In 2023, North America held the largest share in the ECMO device market, primarily due to a high prevalence of chronic cardiac and respiratory diseases, advanced healthcare facilities, and favorable reimbursement policies. Asia-Pacific is forecasted to witness the fastest growth through 2031, driven by expanding healthcare access, government investments in critical care equipment, and a growing patient pool in countries like India and China.

Competitive Scenario:

Key players operating in the Global ECMO Device Market include:

Getinge AB

Medtronic plc

LivaNova PLC

MicroPort Scientific Corporation

Terumo Corporation

Xenios AG (Fresenius Medical Care)

Abbott Laboratories

Eurosets Srl

These companies are focusing on strategic mergers, product portfolio expansion, and innovation in portable and AI-integrated ECMO systems. For instance:

In 2023, Getinge AB launched an upgraded portable ECMO device designed for emergency and transport use.

Medtronic expanded its ECMO training programs globally in 2024 to tackle workforce skill shortages in critical care.

LivaNova PLC introduced a hybrid ECMO-LVAD system for advanced cardiac support in 2025.

Scope of Work – Global Extracorporeal Membrane Oxygenation Device Market

Report Metric Details

Market Size (2023) USD 610 million

Projected Market Size (2031) USD 1.12 billion

CAGR (2023–2031) 7.9%

Market Segments System Type (VA ECMO, VV ECMO, AV ECMO), End-use (Hospitals, Clinics, ASCs)

Growth Drivers Increasing cardiopulmonary disorders, Advancements in ECMO technology

Opportunities Emerging markets, AI integration, Portable ECMO system development

Key Market Developments:

June 2023: Getinge launched a lightweight ECMO system suitable for transport and field use.

January 2024: Terumo Corporation announced a new sensor-optimized ECMO circuit with improved oxygenator lifespan.

March 2025: LivaNova partnered with an AI startup to integrate predictive analytics in ECMO patient monitoring.

FAQs:

1. What is the current market size of the Global Extracorporeal Membrane Oxygenation Device Market?

The market was valued at USD 610 million in 2023.

2. What is the major growth driver